Profound Medical Corp
TSX:PRN
Balance Sheet
Balance Sheet Decomposition
Profound Medical Corp
Current Assets | 41.9m |
Cash & Short-Term Investments | 26.2m |
Receivables | 7.3m |
Other Current Assets | 8.4m |
Non-Current Assets | 2m |
PP&E | 1.5m |
Intangibles | 490k |
Current Liabilities | 6.4m |
Accounts Payable | 3.3m |
Other Current Liabilities | 3.1m |
Non-Current Liabilities | 6.4m |
Long-Term Debt | 5.6m |
Other Non-Current Liabilities | 787k |
Balance Sheet
Profound Medical Corp
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
0
|
8
|
16
|
9
|
23
|
15
|
84
|
67
|
47
|
26
|
|
Cash |
0
|
8
|
16
|
9
|
23
|
15
|
84
|
67
|
47
|
26
|
|
Short-Term Investments |
0
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Receivables |
1
|
0
|
0
|
4
|
2
|
3
|
7
|
1
|
6
|
7
|
|
Accounts Receivables |
0
|
0
|
0
|
3
|
2
|
2
|
6
|
1
|
6
|
7
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
1
|
|
Inventory |
0
|
0
|
0
|
1
|
3
|
4
|
5
|
7
|
8
|
7
|
|
Other Current Assets |
1
|
0
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
|
Total Current Assets |
2
|
15
|
17
|
14
|
28
|
23
|
98
|
77
|
62
|
42
|
|
PP&E Net |
0
|
0
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
|
PP&E Gross |
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
2
|
|
Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
2
|
2
|
3
|
2
|
3
|
|
Intangible Assets |
0
|
0
|
0
|
4
|
3
|
2
|
2
|
1
|
1
|
0
|
|
Goodwill |
0
|
0
|
0
|
3
|
3
|
3
|
3
|
3
|
0
|
0
|
|
Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
0
|
0
|
|
Other Assets |
0
|
0
|
0
|
3
|
3
|
3
|
3
|
3
|
0
|
0
|
|
Total Assets |
2
N/A
|
15
+595%
|
18
+15%
|
22
+26%
|
34
+54%
|
30
-12%
|
105
+248%
|
87
-17%
|
64
-26%
|
44
-32%
|
|
Liabilities | |||||||||||
Accounts Payable |
1
|
1
|
1
|
4
|
3
|
3
|
3
|
3
|
2
|
3
|
|
Short-Term Debt |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
2
|
4
|
1
|
4
|
0
|
0
|
1
|
2
|
|
Other Current Liabilities |
31
|
0
|
0
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
|
Total Current Liabilities |
33
|
1
|
4
|
9
|
6
|
8
|
5
|
4
|
4
|
6
|
|
Long-Term Debt |
2
|
4
|
3
|
0
|
8
|
7
|
1
|
1
|
7
|
6
|
|
Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
1
|
0
|
0
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
|
Total Liabilities |
35
N/A
|
5
-85%
|
7
+27%
|
11
+65%
|
15
+34%
|
16
+8%
|
7
-54%
|
6
-16%
|
12
+102%
|
13
+3%
|
|
Equity | |||||||||||
Common Stock |
0
|
49
|
62
|
78
|
89
|
100
|
212
|
220
|
206
|
217
|
|
Retained Earnings |
33
|
40
|
53
|
72
|
81
|
108
|
130
|
161
|
189
|
218
|
|
Additional Paid In Capital |
1
|
1
|
2
|
5
|
12
|
15
|
11
|
17
|
19
|
20
|
|
Other Equity |
0
|
0
|
0
|
0
|
0
|
7
|
5
|
5
|
17
|
12
|
|
Total Equity |
33
N/A
|
10
N/A
|
11
+9%
|
11
+2%
|
20
+74%
|
14
-26%
|
97
+576%
|
81
-17%
|
52
-35%
|
31
-40%
|
|
Total Liabilities & Equity |
2
N/A
|
15
+595%
|
18
+15%
|
22
+26%
|
34
+54%
|
30
-12%
|
105
+248%
|
87
-17%
|
64
-26%
|
44
-32%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
0
|
4
|
6
|
7
|
11
|
12
|
20
|
21
|
21
|
21
|